|
HY-P701103-10ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P701103-5ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P701103-50ug
|
MedChemexpress LLC
|
MSP/MST1, Mouse (C677A, HEK293)
|
|
|
|
|
HY-P72077-10ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P72077-5ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P72077-50ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse
|
|
|
|
|
HY-P71712-20ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P71712-50ug
|
MedChemexpress LLC
|
Mu ellerian-inhibiting factor/AMH, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P700877-100ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P700877-20ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P700877-50ug
|
MedChemexpress LLC
|
MXRA8, Mouse (HEK293, His)
|
|
|
|
|
HY-P1240B-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240A-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-147136-10mg
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-147136-100mg
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-147136-25mg
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-147136-5mg
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-147136-50mg
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6]
|
|
Cancer-programmed cell death
|
|
|
HY-147136-1mL
|
MedChemexpress LLC
|
MYF-03-176 [CAS 2857937-59-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-N11499-1mg
|
MedChemexpress LLC
|
Myricetin 3-O-Alpha-L-arabinopyranoside [CAS 132679-85-7]
|
|
|
|
|
HY-N11499-5mg
|
MedChemexpress LLC
|
Myricetin 3-O-Alpha-L-arabinopyranoside [CAS 132679-85-7]
|
|
|
|
